218 related articles for article (PubMed ID: 8598477)
21. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.
Ploug M
Biochemistry; 1998 Nov; 37(47):16494-505. PubMed ID: 9843416
[TBL] [Abstract][Full Text] [Related]
22. Granulocyte activation via a binding site near the C-terminal region of complement receptor type 3 alpha-chain (CD11b) potentially involved in intramembrane complex formation with glycosylphosphatidylinositol-anchored Fc gamma RIIIB (CD16) molecules.
Stöckl J; Majdic O; Pickl WF; Rosenkranz A; Prager E; Gschwantler E; Knapp W
J Immunol; 1995 May; 154(10):5452-63. PubMed ID: 7730647
[TBL] [Abstract][Full Text] [Related]
23. Proximity oscillations of complement type 4 (alphaX beta2) and urokinase receptors on migrating neutrophils.
Kindzelskii AL; Eszes MM; Todd RF; Petty HR
Biophys J; 1997 Oct; 73(4):1777-84. PubMed ID: 9336173
[TBL] [Abstract][Full Text] [Related]
24. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).
Magdolen V; Bürgle M; de Prada NA; Schmiedeberg N; Riemer C; Schroeck F; Kellermann J; Degitz K; Wilhelm OG; Schmitt M; Kessler H
Biol Chem; 2001 Aug; 382(8):1197-205. PubMed ID: 11592401
[TBL] [Abstract][Full Text] [Related]
25. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection.
Gyetko MR; Sud S; Kendall T; Fuller JA; Newstead MW; Standiford TJ
J Immunol; 2000 Aug; 165(3):1513-9. PubMed ID: 10903758
[TBL] [Abstract][Full Text] [Related]
26. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells.
Xia Y; Vetvicka V; Yan J; Hanikýrová M; Mayadas T; Ross GD
J Immunol; 1999 Feb; 162(4):2281-90. PubMed ID: 9973505
[TBL] [Abstract][Full Text] [Related]
27. Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and alpha v beta 5 integrin.
Franco P; Vocca I; Carriero MV; Alfano D; Cito L; Longanesi-Cattani I; Grieco P; Ossowski L; Stoppelli MP
J Cell Sci; 2006 Aug; 119(Pt 16):3424-34. PubMed ID: 16882693
[TBL] [Abstract][Full Text] [Related]
28. The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes.
Sitrin RG; Todd RF; Albrecht E; Gyetko MR
J Clin Invest; 1996 Apr; 97(8):1942-51. PubMed ID: 8621779
[TBL] [Abstract][Full Text] [Related]
29. Vitronectin binding to urokinase receptor in human breast cancer.
Carriero MV; Del Vecchio S; Franco P; Potena MI; Chiaradonna F; Botti G; Stoppelli MP; Salvatore M
Clin Cancer Res; 1997 Aug; 3(8):1299-308. PubMed ID: 9815812
[TBL] [Abstract][Full Text] [Related]
30. Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivo.
Pass J; Jögi A; Lund IK; Rønø B; Rasch MG; Gårdsvoll H; Lund LR; Ploug M; Rømer J; Danø K; Høyer-Hansen G
Thromb Haemost; 2007 Jun; 97(6):1013-22. PubMed ID: 17549305
[TBL] [Abstract][Full Text] [Related]
31. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
Nishida Y; Hayashi Y; Imai Y; Itoh H
Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
[TBL] [Abstract][Full Text] [Related]
32. Urokinase-deficient and urokinase receptor-deficient mice have impaired neutrophil antimicrobial activation in vitro.
Gyetko MR; Aizenberg D; Mayo-Bond L
J Leukoc Biol; 2004 Sep; 76(3):648-56. PubMed ID: 15240745
[TBL] [Abstract][Full Text] [Related]
33. Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein.
Zhang G; Cai X; López-Guisa JM; Collins SJ; Eddy AA
J Am Soc Nephrol; 2004 Aug; 15(8):2090-102. PubMed ID: 15284295
[TBL] [Abstract][Full Text] [Related]
34. Physical association of uPAR with the alphaV integrin on the surface of human NK cells.
Gellert GC; Goldfarb RH; Kitson RP
Biochem Biophys Res Commun; 2004 Mar; 315(4):1025-32. PubMed ID: 14985115
[TBL] [Abstract][Full Text] [Related]
35. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
36. Surface-bound immune complexes trigger transmembrane proximity between complement receptor type 3 and the neutrophil's cortical microfilaments.
Zhou MJ; Poo H; Todd RF; Petty HR
J Immunol; 1992 Jun; 148(11):3550-3. PubMed ID: 1534099
[TBL] [Abstract][Full Text] [Related]
37. Nonproteolytic role for the urokinase receptor in cellular migration in vivo.
Waltz DA; Fujita RM; Yang X; Natkin L; Zhuo S; Gerard CJ; Rosenberg S; Chapman HA
Am J Respir Cell Mol Biol; 2000 Mar; 22(3):316-22. PubMed ID: 10696068
[TBL] [Abstract][Full Text] [Related]
38. Cutting edge: evidence for a signaling partnership between urokinase receptors (CD87) and L-selectin (CD62L) in human polymorphonuclear neutrophils.
Sitrin RG; Pan PM; Blackwood RA; Huang J; Petty HR
J Immunol; 2001 Apr; 166(8):4822-5. PubMed ID: 11290756
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18).
Thornton BP; Vĕtvicka V; Pitman M; Goldman RC; Ross GD
J Immunol; 1996 Feb; 156(3):1235-46. PubMed ID: 8558003
[TBL] [Abstract][Full Text] [Related]
40. Receptors for plasminogen activator, urokinase, in normal and Rous sarcoma virus-transformed mouse fibroblasts.
Del Rosso M; Dini G; Fibbi G
Cancer Res; 1985 Feb; 45(2):630-6. PubMed ID: 2981611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
